ECVOCY
Live / Registered — Registered (as of 08 Apr 2025)
What this means for you
Registered since 08 Apr 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Apr 2031: the §8 declaration of use).
Record
- Serial number
- 97377330
- Registration number
- 7755064
- Mark type
- Word mark
- Filed
- 22 Apr 2022
- Published for opposition
- 21 Mar 2023
- Registered
- 08 Apr 2025
- Next maintenance filing
- §8 declaration of use, due by 08 Apr 2031 (grace period to 08 Oct 2031)
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Owner
- Global Blood Therapeutics, Inc., South San Francisco, CA
- Global Blood Therapeutics, Inc., South San Francisco, CA
- Global Blood Therapeutics, Inc., South San Francisco, CA
Prosecution history
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Dec 2024 — USE AMENDMENT FILED
- 22 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 16 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2024 — SOU EXTENSION 3 GRANTED
- 16 Oct 2024 — SOU EXTENSION 3 FILED
- 16 Oct 2024 — SOU TEAS EXTENSION RECEIVED